News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
755,582 Results
Type
Article (44527)
Company Profile (207)
Press Release (710836)
Multimedia
Podcasts (139)
Webinars (23)
Section
Business (241929)
Career Advice (2120)
Deals (36882)
Drug Delivery (149)
Drug Development (83703)
Employer Resources (176)
FDA (16982)
Job Trends (15563)
News (358157)
Policy (34163)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2654)
Accelerated approval (57)
ADA (44)
Adcomms (32)
Allergies (199)
Alliances (51595)
ALS (232)
Alzheimer's disease (1903)
Antibody-drug conjugate (ADC) (549)
Approvals (17471)
Artificial intelligence (776)
ASCO (333)
Autoimmune disease (354)
Automation (65)
Bankruptcy (375)
Best Places to Work (11768)
BIO (69)
BIOSECURE Act (21)
Biosimilars (249)
Biotechnology (131)
Bladder cancer (207)
Brain cancer (79)
Breast cancer (820)
Cancer (6478)
Cardiovascular disease (527)
Career advice (1811)
Career pathing (46)
CAR-T (363)
CDC (61)
Celiac Disease (3)
Cell therapy (992)
Cervical cancer (56)
Clinical research (73297)
Collaboration (2306)
Commercialization (1)
Company closure (5)
Compensation (1551)
Complete response letters (98)
COVID-19 (2830)
CRISPR (125)
C-suite (1311)
Cystic fibrosis (163)
Data (8827)
Decentralized trials (3)
Denatured (41)
Depression (183)
Dermatology (102)
Diabetes (684)
Diagnostics (7148)
Digital health (65)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (382)
Drug pricing (222)
Drug shortages (34)
Duchenne muscular dystrophy (314)
Earnings (94057)
Editorial (71)
Employer branding (21)
Employer resources (158)
Events (123743)
Executive appointments (1176)
FDA (21126)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1897)
Gene editing (260)
Generative AI (66)
Gene therapy (783)
GLP-1 (1152)
Government (4899)
Grass and pollen (7)
Guidances (423)
Healthcare (19343)
Hematology (195)
HIV (90)
Huntington's disease (66)
IgA nephropathy (117)
Immunology and inflammation (320)
Immuno-oncology (110)
Indications (225)
Infectious disease (3202)
Inflammatory bowel disease (231)
Inflation Reduction Act (14)
Influenza (144)
Intellectual property (327)
Interviews (332)
IPO (16966)
IRA (57)
Job creations (4077)
Job search strategy (1502)
JPM (65)
Kidney cancer (22)
Labor market (114)
Layoffs (608)
Leadership (44)
Legal (8428)
Liver cancer (104)
Longevity (36)
Lung cancer (857)
Lymphoma (485)
Machine learning (67)
Management (62)
Manufacturing (1216)
Marketing (7)
MASH (218)
Medical affairs (1)
Medical device (14101)
Medtech (14282)
Mergers & acquisitions (21255)
Metabolic disorders (1712)
mRNA (246)
Multiple sclerosis (202)
NASH (18)
Neurodegenerative disease (483)
Neuropsychiatric disorders (116)
Neuroscience (3599)
Neurotech (1)
NextGen: Class of 2026 (6650)
Non-profit (4590)
Now hiring (83)
Obesity (789)
Opinion (325)
Ovarian cancer (244)
Pain (288)
Pancreatic cancer (358)
Parkinson's disease (399)
Partnered (37)
Patents (663)
Patient recruitment (798)
Peanut (70)
People (62055)
Pharmaceutical (52)
Pharmacy benefit managers (35)
Phase 1 (22754)
Phase 2 (32261)
Phase 3 (24134)
Pipeline (10213)
Policy (350)
Postmarket research (2662)
Preclinical (9679)
Press Release (68)
Prostate cancer (341)
Psychedelics (64)
Radiopharmaceuticals (357)
Rare diseases (1247)
Real estate (6325)
Recruiting (73)
Regulatory (26868)
Reports (57)
Research institute (2478)
Resumes & cover letters (363)
Rett syndrome (46)
RNA editing (27)
RSV (90)
Schizophrenia (193)
Series A (324)
Series B (239)
Service/supplier (7)
Sickle cell disease (127)
Special edition (28)
Spinal muscular atrophy (172)
Sponsored (49)
Startups (3803)
State (2)
Stomach cancer (19)
Supply chain (139)
Tariffs (99)
The Weekly (96)
Vaccines (1187)
Venture capital (125)
Weight loss (513)
Women's health (139)
Worklife (21)
Date
Today (110)
Last 7 days (410)
Last 30 days (2029)
Last 365 days (30983)
2026 (17255)
2025 (30671)
2024 (35656)
2023 (40626)
2022 (51798)
2021 (56325)
2020 (54788)
2019 (47395)
2018 (35768)
2017 (33134)
2016 (32666)
2015 (38630)
2014 (32540)
2013 (27656)
2012 (29748)
2011 (30497)
2010 (28504)
Location
Africa (808)
Alabama (95)
Alaska (7)
Arizona (374)
Arkansas (16)
Asia (42948)
Australia (6897)
California (14225)
Canada (4043)
China (1571)
Colorado (606)
Connecticut (619)
Delaware (441)
Europe (92523)
Florida (2157)
Georgia (451)
Hawaii (3)
Idaho (63)
Illinois (1183)
India (105)
Indiana (648)
Iowa (24)
Japan (621)
Kansas (136)
Kentucky (52)
Louisiana (60)
Maine (78)
Maryland (1681)
Massachusetts (10228)
Michigan (380)
Minnesota (767)
Mississippi (6)
Missouri (152)
Montana (33)
Nebraska (30)
Nevada (152)
New Hampshire (84)
New Jersey (3724)
New Mexico (31)
New York (3751)
North Carolina (1801)
North Dakota (9)
Northern California (7184)
Ohio (422)
Oklahoma (25)
Oregon (43)
Pennsylvania (2827)
Puerto Rico (31)
Rhode Island (52)
South America (1181)
South Carolina (90)
South Dakota (2)
Southern California (5661)
Tennessee (232)
Texas (2287)
United States (50258)
Utah (424)
Vermont (2)
Virginia (357)
Washington D.C. (81)
Washington State (1134)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
755,582 Results for "arrowhead pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
MASH
Madrigal picks up another siRNA asset for MASH, betting up to $1B with Arrowhead
Madrigal Pharmaceuticals has licensed from Arrowhead Pharmaceuticals an RNA interference candidate that targets a genetic mutation present in around 30% of patients with MASH.
May 5, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events
June 2, 2026
·
4 min read
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming May 2026 Events
May 4, 2026
·
5 min read
Press Releases
Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results
May 8, 2026
·
13 min read
Press Releases
Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars
June 19, 2026
·
5 min read
Press Releases
Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals
May 5, 2026
·
6 min read
Press Releases
Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
June 23, 2026
·
9 min read
Press Releases
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results
April 21, 2026
·
4 min read
Press Releases
Arrowhead Pharmaceuticals Presents New Clinical Data on RNAi-based Obesity and MASH Candidate ARO-INHBE at EASL 2026
May 27, 2026
·
7 min read
Press Releases
Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress
May 26, 2026
·
8 min read
1 of 75,559
Next
